Community
Slovak prosecutor reopens probe into fighter jet donation to Ukraine
By Jenna Larson
India’s Sun Pharma posts lower quarterly profit on one-time acquisition-related charge
Jenna Larson
Jenna Larson
Bureau Chief · Fargo, ND
Jenna Larson has been reporting on the Fargo region for over 15 years. She graduated from North Dakota State University and began her career at The Forum of Fargo-Moorhead before joining the Bison Current network. Jenna's focus is on community events, local initiatives, and the stories that make Fargo unique.
More from Jenna →Bureau Chief · Friday, October 30, 2026 at 8:57 AM · 1 min read
Oct 30 (Reuters) India s Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, dragged by a one-time charge related to its acquisition of Organon. Consolidated net profit fell to 19.89 billion rupees ($209.31 million) in the quarter ended September 30 from 31.18 billion rupees a year earlier. The drugmaker booked a one-time charge of 12.69 billion rupees, largely comprising acquisition-related costs for its planned purchase of Organon, along with provisions linked to India s new labour code framework. ($1 = 95.0250 Indian rupees) (Reporting by Kashish Tandon in Bengaluru; Editing by Jochelle Mendonca)
Up nextSlovak prosecutor reopens probe into fighter jet donation to UkraineCommunity · 1 min read
